ArticlePharmacoEconomics - open2022

Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide.

Dikshyanta Rana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.